Weronika Piekarska

Weronika Piekarska

Auto-generated profile, based on publicly available information

Weronika Piekarska

Medical University of Lodz, Aleja T. Kościuszki 4, 90–419 Łódź, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
WPWeronika Piekarska
Weronika Piekarska
MSMichelle Martina Stachurska
Michelle Martina Stachurska
JFJęDrzej Marek Foryński
JęDrzej Marek Foryński
NSNikola Agnieszka Samp
Nikola Agnieszka Samp
KZKamila Zera
Kamila Zera
PTPaweł Arkadiusz Trzepizur
Paweł Arkadiusz Trzepizur
Background. Age-related decline in muscle mass, strength, metabolic health and cognitive function is a major contributor to reduced functional independence in older adults. Creatine supplementation has emerged as a potential nutritional intervention due to its role in cellular energy metabolism; however, its efficacy and safety in aging populations remain topics of ongoing investigation. Aim. To critically evaluate, in a narrative review format, the current evidence regarding the efficacy and safety of creatine supplementation in older adults, with particular emphasis on outcomes related to skeletal muscle function, bone health, cardiometabolic outcomes, cognitive performance, neuroprotection and reported adverse effects. Material and methods. A narrative synthesis of literature indexed in PubMed was conducted, focusing on studies examining creatine supplementation in adults aged ≥55 years. Particular attention was given to randomized controlled trials, systematic reviews, and meta-analyses published in recent years. Results. Evidence consistently indicates that creatine supplementation, particularly when combined with resistance training, improves lean body mass, muscle strength, and selected functional performance measures in older adults. The effects on bone health appear limited and are likely indirect, mediated through enhanced muscle function. Emerging findings suggest potential benefits for cognitive performance, especially in memory-related domains. However, current evidence is insufficient to confirm clinically relevant neuroprotective effects. Conclusions. Creatine supplementation may be considered a safe and effective adjunct strategy for supporting musculoskeletal health and functional capacity in aging populations. Its broader effects require further long-term studies in diverse older populations.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MJMikołaj Jońca
Mikołaj Jońca
GMGabriela Majchrowicz
Gabriela Majchrowicz
NKNatasza Kurys
Natasza Kurys
WPWeronika Piekarska
Weronika Piekarska
SLSzymon Litke
Szymon Litke
KGKatarzyna Gołacka
Katarzyna Gołacka
Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder and the leading cause of dementia worldwide, with prevalence increasing due to population aging. It is characterized by cognitive decline, functional impairment, and significant public health burden. Pathophysiology involves a complex interplay of amyloid-β (Aβ) accumulation, tau pathology and neuroinflammation. Despite extensive research, current pharmacological management of Alzheimer’s disease relies primarily on symptomatic therapies and does not alter the underlying neurodegenerative process. The aim of this review is to summarize the current state of knowledge on therapeutic strategies for AD, with particular emphasis on lecanemab, a recombinant humanized antibody characterized by their selectivity for soluble Aβ oligomers. We discuss its mechanism of action, clinical evidence from recent randomized controlled trials assessing its efficacy and safety. In this review, lecanemab is not only addressed in the context of established and widely used therapies but also alongside novel treatments currently being tested. Lecanemab represents a significant step towards disease-modifying therapy for AD as it reduces brain amyloid. Although the available results are promising, current evidence suggests that monotherapeutic interventions targeting a single pathological mechanism may be insufficient to completely stop or reverse disease progression underscoring the need for further research to optimize therapeutic outcomes.

5 June 2026 in Quality in Sport
Verified
Journal Article
Open access
PTPaweł Arkadiusz Trzepizur
Paweł Arkadiusz Trzepizur
NSNikola Agnieszka Samp
Nikola Agnieszka Samp
BBBeniamin Andrzej Bekrycht
Beniamin Andrzej Bekrycht
JFJęDrzej Marek Foryński
JęDrzej Marek Foryński
MSMichelle Martina Stachurska
Michelle Martina Stachurska
RWRafał Wilczyński
Rafał Wilczyński
Background. Attention deficit hyperactivity disorder (ADHD) affects approximately 7.2% of children and adolescents internationally and is associated with functional impairment across educational, social, occupational, and health behavioral domains. Despite evidence that physical activity benefits cognition and psychosocial functioning, participation remains markedly insufficient, with only 6.5% of adolescents with ADHD meeting all recommended movement guidelines. Aim. To synthesize evidence on physical activity levels, sport participation, exercise types, barriers and facilitators, sex differences, and dose effects in individuals with ADHD. Material and methods. PubMed search (January 2015 – May 2026); studies reporting physical activity, sport participation, or exercise outcomes in individuals with ADHD. Findings were synthesized narratively. Results. Several forms of physical activity — aerobic exercise, martial arts, racket sports, swimming, equine-assisted activities, target shooting, exergaming, combined aerobic-cognitive exercise, and multicomponent school-based programs — were associated with improvements in cognitive, behavioral, or psychosocial outcomes. Barriers were primarily related to executive dysfunction, motivational difficulties, and low self-esteem; facilitators were largely tied to direct experience of the benefits of exercise. Conclusions. Individuals with ADHD engage in physical activity at markedly insufficient levels and face distinctive barriers rooted in executive dysfunction and motivational dysregulation. Multiple forms of physical activity produced meaningful benefits, suggesting interventions need not be restricted to aerobic exercise alone. Sex-specific factors and exercise intensity warrant explicit consideration in intervention design.

16 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
RWRafal Wilczynski
Rafal Wilczynski
NSNikola Samp
Nikola Samp
JFJęDrzej Foryński
JęDrzej Foryński
MSMichelle Stachurska
Michelle Stachurska
PTPaweł Trzepizur
Paweł Trzepizur
KRKarolina Rogala
Karolina Rogala
Background. Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in athletes are rare but devastating events. Traditional prevention relies on preparticipation cardiovascular screening, which may not identify intermittent or exercise-induced abnormalities. Wearable technologies offer continuous cardiovascular monitoring and may support early detection of potential abnormalities. Aim. To evaluate the role of wearable devices in cardiovascular monitoring of athletes and their potential contribution to SCA/SCD prevention. Material and methods. A narrative review was performed using PubMed, Scopus, and Google Scholar. Original studies, reviews, and consensus statements on wearable devices, arrhythmia detection, heart rate variability, and SCA/SCD in athletes were analyzed qualitatively, with emphasis on recent literature. Results. Wearable devices based on photoplethysmography (PPG) and wearable electrocardiography (ECG) allow monitoring of cardiovascular parameters during daily activity and exercise. Wearable ECG offers greater diagnostic value for arrhythmia detection, whereas PPG enables long-term monitoring but is more susceptible to artifacts. Heart rate variability and other derived metrics may reflect autonomic regulation, although their value in predicting serious cardiac events remains uncertain. Current evidence supports wearables as adjunctive tools for symptom evaluation and longitudinal monitoring rather than standalone preventive methods. Conclusions. Wearable technologies show promise for cardiovascular monitoring in athletes but should currently complement rather than replace established screening strategies. Further prospective studies and standardized clinical guidelines are needed to define their role in sports cardiology.

15 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
GMGabriela Majchrowicz
Gabriela Majchrowicz
MJMikołaj Jońca
Mikołaj Jońca
NKNatasza Kurys
Natasza Kurys
WPWeronika Piekarska
Weronika Piekarska
SLSzymon Litke
Szymon Litke
Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder characterized by extremely elevated low-density lipoprotein cholesterol (LDL-C) levels and a markedly increased risk of premature atherosclerotic cardiovascular disease. The aim of this review was to summarize current knowledge on the pathophysiology, diagnosis, and management of HoFH, with particular emphasis on angiopoietin-like protein 3 (ANGPTL3) inhibition and the clinical role of evinacumab. A comprehensive analysis of published clinical trials, guidelines, and observational studies was conducted to evaluate available diagnostic criteria and therapeutic strategies. Standard lipid-lowering therapies often fail to achieve recommended LDL-C targets in HoFH due to impaired LDL receptor function. Evinacumab, a fully human monoclonal antibody targeting ANGPTL3, has demonstrated substantial LDL-C reductions independent of LDL receptor activity in both adult and pediatric patients. Clinical studies report LDL-C reductions of approximately 45–50%, along with a favorable safety profile. In conclusion, ANGPTL3 inhibition with evinacumab represents a significant advancement in the treatment of HoFH, offering an effective therapeutic option for patients with inadequate response to conventional lipid-lowering therapies.

11 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NSNikola Agnieszka Samp
Nikola Agnieszka Samp
PTPaweł Arkadiusz Trzepizur
Paweł Arkadiusz Trzepizur
KZKamila Zera
Kamila Zera
BBBeniamin Andrzej Bekrycht
Beniamin Andrzej Bekrycht
JFJęDrzej Marek Foryński
JęDrzej Marek Foryński
RWRafał Wilczyński
Rafał Wilczyński
Background: ADHD is characterized by inattention, hyperactivity, impulsivity, and affects 8.4% of children and 2.5% of adults. Lower diagnosis rates in females suggest a different clinical presentation, contributing to delayed diagnoses and negative outcomes across multiple domains of functioning. Aim: This study examines underdiagnosed ADHD in women, assessing its impact on functioning in adulthood, including mental health, quality of life, and long-term impairments. Material and methods: A literature review using PubMed/MEDLINE (2010–2025) included clinical, longitudinal cohort, and epidemiological research addressing sex differences in ADHD diagnosis, symptom presentation, and long-term functional outcomes, with a focus on the female population. Results: Women with ADHD are significantly underdiagnosed in childhood, often receiving diagnosis only in adulthood after years of treatment for comorbidities such as anxiety, depression, or personality disorders. Internalized symptoms and emotional dysregulation frequently mask core ADHD features. Late diagnosis is associated with impaired educational and occupational achievement, relationship instability, low self-esteem, substance misuse, reduced quality of life, and increased risk of self-harm and suicide attempts. ADHD in women also increases risk of psychiatric and obstetric complications, including teenage pregnancy, smoking during pregnancy, substance misuse, and postpartum depression and anxiety. Conclusions: Underdiagnosis of ADHD in women remains a significant clinical and public health issue. Greater awareness of sex-specific symptom presentation and improved diagnostic strategies are essential to prevent long-term psychosocial consequences and improve quality of life in affected women.